Construct: ORF TRCN0000477800
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF010880.1_s317c1
- Derived from:
- ccsbBroadEn_05830
- DNA Barcode:
- GTGCTTAGGGTTCGAATAACGTTA
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- APBA2 (321)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000477800
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001130414.1 | 99.9% | 99.8% | 932T>C;1773C>T |
2 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353792.2 | 99.9% | 99.8% | 932T>C;1773C>T |
3 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353793.2 | 99.9% | 99.8% | 932T>C;1773C>T |
4 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353794.2 | 99.9% | 99.8% | 932T>C;1773C>T |
5 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_024449909.1 | 99.6% | 99.5% | 932T>C;1214_1219delAGGTAG;1779C>T |
6 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353788.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
7 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353789.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
8 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353790.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
9 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353791.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
10 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_005503.3 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
11 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_011521488.3 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
12 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_011521489.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
13 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_011521490.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
14 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_011521491.1 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
15 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_011521492.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
16 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_017022110.1 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
17 | human | 321 | APBA2 | amyloid beta precursor prot... | XM_017022112.2 | 98.3% | 98.2% | 932T>C;1215_1250del;1809C>T |
18 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353795.2 | 90.7% | 89.2% | (many diffs) |
19 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353797.2 | 58.8% | 57.6% | (many diffs) |
20 | human | 321 | APBA2 | amyloid beta precursor prot... | NM_001353796.2 | 57.9% | 56.7% | (many diffs) |
21 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | XM_006540576.3 | 87.6% | 92.4% | (many diffs) |
22 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | NM_001291166.1 | 86.2% | 90.9% | (many diffs) |
23 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | NM_001291167.1 | 86.2% | 90.9% | (many diffs) |
24 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | NM_007461.2 | 86.2% | 90.9% | (many diffs) |
25 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | XM_006540573.3 | 86.2% | 90.9% | (many diffs) |
26 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | XM_006540574.3 | 86.2% | 90.9% | (many diffs) |
27 | mouse | 11784 | Apba2 | amyloid beta (A4) precursor... | XM_017321945.1 | 86.2% | 90.9% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 2280
- ORF length:
- 2211
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 ttggcaccat ggcccaccgg aagcttgaga gcgtggggag cggcatgttg gaccataggg 121 tgagaccagg tcctgtccct cacagccagg agcccgagag cgaggacatg gagctgccct 181 tggagggcta tgtgcccgag ggcctggagc tggctgccct gcggccagag agccccgcgc 241 cagaggaaca ggagtgccac aaccacagcc ccgatgggga ctccagctct gactacgtga 301 acaacacctc tgaggaggag gactatgacg agggcctccc tgaggaggag gagggcatca 361 cctactacat ccgctactgc cctgaggacg acagctacct agagggcatg gactgcaacg 421 gggaggagta cctggcccac agtgcacacc ctgtggacac tgatgagtgc caggaggcgg 481 tggaggagtg gacggactcg gcgggcccgc acccccacgg ccacgaggct gaaggcagcc 541 aggactaccc agacggccaa ctgcccattc cggaggatga gccctccgtc cttgaggccc 601 atgaccagga agaagatggt cactactgtg ccagcaaaga gggctaccag gactactacc 661 ccgaggaggc caacgggaac accggcgcct ccccctaccg cctgaggcgt ggggatgggg 721 acctggagga ccaggaggag gacattgacc agatcgtggc agagatcaag atgagtctga 781 gcatgaccag catcaccagc gccagtgagg ccagccccga gcatgggcct gagccagggc 841 ctgaggactc tgtagaggcc tgcccaccca tcaaggccag ctgcagcccc agcaggcacg 901 aggcgaggcc caagtcgctg aacctccttc ccgaggccaa gcaccccgga gacccccaga 961 gaggcttcaa gcccaagacc aggaccccag aagagaggcc gaagtggccc cacgagcagg 1021 tttgcaatgg tctggagcag ccaaggaagc agcagcgctc tgatctcaat ggacctgttg 1081 acaataacaa cattccagag acaaagaagg tggcatcatt tccaagtttt gtggctgttc 1141 cagggccctg cgaaccagaa gacctcatcg acgggatcat ctttgctgcc aattacctgg 1201 ggtccaccca gctgctatca gaacggaacc cttccaaaaa catcagaatg atgcaagcgc 1261 aggaggccgt cagccgggtc aagaattctg agggggatgc ccagacgctg acggaagtgg 1321 acctcttcat ttccacccag aggatcaagg ttttaaatgc agacacgcag gaaaccatga 1381 tggaccacgc cttgcgtacc atctcctaca tcgccgacat tgggaacatt gtagtgctga 1441 tggccagacg ccgcatgccc cggtcagcct ctcaggactg catcgagacc acgcccgggg 1501 cccaggaagg caagaagcag tataagatga tctgccatgt gttcgagtcg gaggatgccc 1561 agctcatcgc ccagtctatc ggccaggcct tcagcgtggc ctaccaggag ttcctgcgag 1621 ccaatggcat caaccccgaa gacttgagcc agaaggaata cagcgacatc atcaacaccc 1681 aggagatgta caacgacgac ctcatccact tctcaaactc ggagaactgc aaggagctgc 1741 agctggagaa gcacaagggc gagatcctgg gcgtggtggt ggtggagtcg ggctggggct 1801 ccatcctgcc cacggtgatc ctggccaaca tgatgaatgg tggcccggct gcccgctcgg 1861 ggaagctgag catcggggac cagatcatgt ccatcaatgg caccagcctg gtggggctgc 1921 ccctcgccac ctgccaaggc atcatcaagg gcctgaagaa ccagacacag gtgaagctca 1981 acattgtcag ctgtcccccg gtcaccacgg tccttatcaa gcggccagac ctcaagtacc 2041 agctgggctt cagcgtgcag aatggaatta tctgcagcct catgagaggg ggcattgcTG 2101 AGCGAGGGGG CGTCCGTGTG GGCCACCGCA TCATCGAGAT CAACGGGCAG AGCGTGGTGG 2161 CCACAGCCCA CGAGAAGATA GTCCAAGCTC TGTCCAACTC GGTCGGAGAG ATCCACATGA 2221 AGACCATGCC CGCCGCCATG TTCAGGCTCC TCACGGGTCA GGAGACCCCG CTGTACATCT 2281 TGCCAACTTT CTTGTACAAA GTGGTTGATA TCGGTAAGCC TATCCCTAAC CCTCTCCTCG 2341 GTCTCGATTC TACGTAGTAA TGAACTAGTC CGTAACTTGA AAGTATTTCG ATTTCTTGGC 2401 TTTATATATC TTGTGGAAAG GACGAGTGCT TAGGGTTCGA ATAACGTTAA CGCGTTAAGT 2461 Cgacaatcaa cctctggatt acaaaatttg tgaaagatt